4BB Insider Trading (4basebio)
Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): £90,021.50
Insider Selling (Last 12 Months): GBX 0
4basebio Share Price & Price History
Current Price: GBX 414
Price Change: ▼ Price Decrease of -6 (-1.43%)
As of 06/30/2022 03:00 PM ET
Former Lawyer Went From $50K To $5.3M Trading Options
From Investing Daily | Ad
Slaving away for 70 hrs a week as a lawyer in Chicago, I was miserable.
I ran into guys who worked the trading floor at the local exchange. I began trading the same way they did. I started out with $50K (much more than I needed, actually).
I grew my $50K into $5.3M
I'll show you how I did it here.
4basebio Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 6/16/2022 | David John Roth | Insider | Buy | 5,000 | GBX 430 | £21,500 | | |
| 5/12/2022 | Heikki Lanckriet | Insider | Buy | 3,000 | GBX 470 | £14,100 | | |
| 5/9/2022 | Heikki Lanckriet | Insider | Buy | 500 | GBX 500 | £2,500 | | |
| 12/20/2021 | Heikki Lanckriet | Insider | Buy | 1,000 | GBX 650 | £6,500 | | |
| 12/17/2021 | Heikki Lanckriet | Insider | Buy | 1,500 | GBX 650 | £9,750 | | |
| 12/13/2021 | Heikki Lanckriet | Insider | Buy | 3,000 | GBX 652 | £19,560 | | |
| 7/1/2021 | Heikki Lanckriet | Insider | Buy | 3,450 | GBX 467 | £16,111.50 | | |
| 2/25/2021 | Heikki Lanckriet | Insider | Buy | 3,000 | GBX 345 | £10,350 | | |
27 U.S. Cities Where Stocks Yield 26% a Year
From Investing Daily | Ad
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!
When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.
SEC Filings (Institutional Ownership Changes) for 4basebio (LON:4BB)
4basebio UK Societas develops gene therapy technologies and solutions primarily in the United Kingdom. It focuses on the manufacture and supply of synthetic DNA and non-viral nanoparticles for research, therapeutic, and pharmacological use. The company provides services for biotech and pharma customers in the gene therapy and gene vaccine development. It is also involved in the manufacture of enzymes that are used for diagnostic and laboratory test kits. The company was formerly known as 4Basebio SE and changed its name to 4basebio UK Societas in December 2020. 4basebio UK Societas was incorporated in 2020 and is based in Cambridge, United Kingdom.
Read More on 4basebio
Today's Range
Now: GBX 414
50 Day Range
MA: GBX 474.24
52 Week Range
Now: GBX 414
Volume
2,964 shs
Average Volume
2,011 shs
Market Capitalization
£50.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Who are the company insiders with the largest holdings of 4basebio?
